D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
about
Up-regulation of RhoGDI2 in human breast cancer and its prognostic implicationsTargeting Cdc42 in cancerThe faces and friends of RhoGDI2.Functional characterization of E- and P-cadherin in invasive breast cancer cells.RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.Placenta-specific novel splice variants of Rho GDP dissociation inhibitor β are highly expressed in cancerous cells.P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.Pleiotropic functions of Rho GTPase signaling: a Trojan horse or Achilles' heel for breast cancer treatment?RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis.Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells.Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancerRhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.Centrosomal localization of RhoGDIβ and its relevance to mitotic processes in cancer cellsSilencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signalingThe role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis.RhoGDI2 as a therapeutic target in cancer.Perineural invasion and associated pain in pancreatic cancer.Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantationEvolution of tumor invasiveness: the adaptive tumor microenvironment landscape model.Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway.Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.GM3 suppresses anchorage-independent growth via Rho GDP dissociation inhibitor beta in melanoma B16 cells.The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathwayRhoGDI2 confers resistance to 5-fluorouracil in human gastric cancer cells.Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma.Comparative Study of Folic Acid and α-Naphthoflavone on Reducing TCDD-Induced Cleft Palate in Fetal Mice.Rho GDP dissociation inhibitor-β in renal cell carcinoma.XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.RhoGDI2 expression in astrocytes after an excitotoxic lesion in the mouse hippocampus.VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.Overexpression and clinical significance of IBP in epithelial ovarian carcinoma.
P2860
Q24632730-73934519-68E8-4CA6-84A4-11C895077027Q27028075-6DD130DB-5EA7-4DC3-BDDE-71E738C1938DQ30455699-21B903F2-816C-4F42-8DBC-34353F263EA6Q33414412-30B09B72-6D94-4B57-B909-1F2C0F4587A0Q33688924-8B9DD129-D44B-4CF7-B2B0-1D45908CD4B3Q34124807-00C1D73D-48A2-4976-B417-B2733E24DFE3Q34498722-D9679078-0C46-475F-B5AB-3822F9B9ACA3Q34989045-3FE71454-5B5A-4717-A214-2DD02CFCF75FQ35287780-35EDF3A7-8E93-47F7-969D-DFA8C314AF9CQ35578252-0F919845-7A84-4366-8FA9-B50CA6A97A30Q36188915-86AFA22A-778F-47EA-B82E-5FAF4C433257Q36414288-97A74D80-596A-4700-AC4D-493ECC167C1BQ36544952-8A9653DA-25E4-47C6-9FB6-1D57C7B072E2Q36643144-2F41778B-CF3D-4AE4-8CC0-D73EEE7FE8AEQ37176427-5685F81E-3CA1-4546-B49E-C27E632FE66EQ37302918-40A646E2-8CF2-4ACC-B04F-24980342C651Q37420185-A79E026D-F393-4321-9202-CBD42E3BA326Q37626077-7C72A8DD-06D4-42E7-8D07-316BAA49ACE2Q37650185-3473702E-FB53-4E42-A5E0-C4326F98EE40Q37937421-50641416-B175-4518-8291-A16DBABF041EQ38695493-494DD2C6-6B98-434A-9A16-A92B1C650D6CQ38761102-6BCCEAEA-4444-4E5E-B0E1-B258D7A5DC2FQ38889577-75F4241D-95E4-4983-9649-A9104FECE065Q38953542-EDA6C43A-D668-4BEB-9B17-9A0828E187DFQ39204898-996EB977-7CC5-44F2-BB88-6C5AA80B4A4BQ39439840-C25CE090-2D11-48E5-A6B1-52B82B4CB079Q39485959-3EB8208E-2113-4329-97E4-E6A79F6069DDQ39553492-3BEA7232-E62A-420B-9FF0-43A1224337ECQ41783109-7F1234DF-D30B-4666-80E0-37E04C48CE0CQ41967598-E89AF71F-AB45-46DC-B4AA-240436454A6AQ42100478-AC679DF8-6B50-4839-B1B3-237954E0CCFBQ42468963-3AF4D6F0-AA40-4B92-990B-E76D77C28EE6Q46573178-B13D7440-3E62-44F3-BBAD-12224B3CDA8FQ47096248-6CEB907A-40C7-4240-8B4D-E664C2012F80Q47282727-F051C24B-DC7E-437C-A5BC-CBB4479ED0BBQ48287444-1459FFEB-FA43-4201-94D7-75D9A55117F3Q48501851-B175D885-D75B-461C-8008-D858F05E582AQ54220504-70EE723C-BDBC-480E-88F8-2A3A70F5C385Q55263313-A5290C75-C2C9-4E5E-BD54-E73A0E8107CE
P2860
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@ast
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@en
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@nl
type
label
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@ast
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@en
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@nl
prefLabel
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@ast
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@en
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@nl
P3181
P1433
P1476
D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness
@en
P2093
Baolin Zhang
Yaqin Zhang
P304
P3181
P356
10.1158/0008-5472.CAN-05-4004
P407
P577
2006-06-01T00:00:00Z